ENVB
Enveric Biosciences, Inc.
There isn't enough reported data to score ENVB yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
ENVB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ENVB's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ENVB PE Valuation
ENVB has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ENVB Forward outlook
There aren't enough analyst estimates for ENVB to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ENVB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$25.55 | +$109.18 |
| Q1 2026 | -$36.43 | +$131.66 |
| Q4 2025 | -$49.99 | +$213.26 |
| Q3 2025 | -$102.34 | +$354.86 |
| Q2 2025 | -$134.73 | +$513.27 |
| Q1 2025 | -$168.09 | +$982.11 |
| Q4 2024 | -$263.25 | +$1,192.95 |
| Q3 2024 | -$457.20 | +$2,305.80 |
ENVB lost $25.55 per share over the past year, a smaller loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over ENVB on earnings quality, reporting a profit while its opponent remains loss making.
ENVB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2020 | $8.5M | -7.3% |
UNH has the edge over ENVB in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2020 | -13% | +3.9 points |
| Q2 2020 | -14% | N/A |
| Q1 2020 | -17% | N/A |
| Q4 2019 | -22% | N/A |
| Q3 2019 | -17% | N/A |
ENVB's operating margin was −13% last quarter, up 3.9 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over ENVB in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ENVB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.4M | -$554.4K |
| Q1 2026 | -$2.3M | +$134.7K |
| Q4 2023 | -$1.8M | +$1.7M |
| Q3 2023 | -$2.7M | +$1.8M |
| Q2 2023 | -$4.5M | +$173.1K |
| Q1 2023 | -$5.1M | -$87.7K |
| Q4 2022 | -$3.5M | +$599K |
| Q3 2022 | -$4.6M | -$2.4M |
ENVB has burned cash in almost every quarter: −$9M over the past year, against −$9M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ENVB on cash generation, producing positive trailing cash flow while its opponent burns cash.
ENVB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +164% | +2.5M shares |
| 1 year | +1743% | +3.8M shares |
| 3 years | +33951% | +4M shares |
| 5 years | +623857% | +4M shares |
| Available history | +6645040% | +4M shares |
ENVB has 4M diluted shares, up 1743% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ENVB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ENVB Net Leverage
ENVB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ENVB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 53.9 | Neutral |
ENVB's weekly RSI is 41 (neutral) and its Stochastic is 54 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ENVB PE vs Healthcare Sector
ENVB has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ENVB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.45 | 4.8% above |
| 20 week MA | $1.45 | 4.8% above |
| 50 week MA | $2.33 | 35% below |
| 100 week MA | $11.2 | 86% below |
| 200 week MA | $141.9 | 99% below |
ENVB has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 99% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ENVB on trend strength, trading above more of its moving averages.
ENVB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86,400.0 | $60,840.0 | -30% |
| 2021 | $60,840.0 | $9,630.0 | -84% |
| 2022 | $9,630.0 | $316.8 | -97% |
| 2023 | $316.8 | $234.0 | -26% |
| 2024 | $234.0 | $62.5 | -73% |
| 2025 | $62.5 | $4.11 | -93% |
| 2026 YTD | $4.11 | $1.52 | -63% |
ENVB has finished every year since 2020 lower, and it's down 63% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ENVB on returns for 2026, with the stronger performance.